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Abstract
The purpose of this research was to present 
the latest development of the The Perceived 
Emotional Distress Inventory (PEDI) as a brief 
15-item self-report measure intended to be used 
for the assessment of psychological distress in 
cancer patients. Factor Analyses of Principal 
Components with promax rotations were 
performed with a combined male and female 
sample of 481 cancer patients at St. Joseph’s 
hospital Cancer Institute in Tampa, Florida, to 
provide further evidence of construct validity. 
The factor structure, internal consistency, 
and Pearson correlation coefficients of the 
PEDI are presented in this report. The factor 
analysis identified three factors comparable 
to those found in previous samples in USA: 
The first factor, anxiety/depression; second 
factor, hopelessness; and third factor, anger 
expression. Global alpha coefficient of 0.92 
for the inventory indicates strong internal 
consistency. Pearson correlations between the 
subscales of the instrument is impressive for 
such a brief measure. This study emphasizes 
the need for a brief, self-report instrument to 
assess anger expression, anxiety, depression 
and hopelessness as components of perceived 
emotional distress in cancer patients, while 
explicitly excluding the potentially confounding 
effects of somatic symptoms commonly 
associated with cancer treatments. Further 
Resumen
El propósito de este estudio fue evaluar 
la estructura factorial del Inventario de Ma-
lestar Emocional Percibido (IDEP), un instru-
mento de medición del malestar emocional 
de 15 ítems, en una muestra de 481 pacien-
tes con cáncer que iniciaron sus tratamien-
tos con radioterapia y/o quimioterapia en el 
Instituto de cancer del hospital St. Joseph’s 
en la ciudad de Tampa, Florida, USA. Se llevó 
a cabo un análisis factorial de componentes 
principales y método de rotación promax 
con autovalores superiores a 1. El primer 
factor contiene seven ítems correspondien-
tes a síntomas de ansiedad y depresión. El se-
gundo factor está agrupado por cuatro ítems 
relacionados con sentimientos de desespe-
ranza, mientras un tercer factor presenta 
cuatro ítems que manifiestan la expresión de 
ira. Los resultados obtenidos nos indican que 
el Inventario de malestar emocional presen-
ta una estructura factorial consistente con 
el marco conceptual en el cual se basó la 
construcción del instrumento, El coeficiente 
alpha de Cronbach para el instrumento total 
del IDEP es de 0,92, lo cual es significativa-
mente elevado, como también los coeficien-
tes alpha para sus cuatro sub-escalas. Los 
resultados observados demuestran evidencia 
empírica acerca de la validez de constructo y 
la consistencia interna del IDEP. Es necesario 
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research will be needed to provide information 
about the PEDI’s use in populations other 
than cancer patients including attempts to 
replicate these findings in more heterogeneous 
populations.
Keywords: Cancer, emotional distress, 
anxiety, anger, hopelessness, depression.
un mayor esfuerzo con el propósito de re-
plicar estos mismos resultados en pacientes 
con otros tipos de diagnostico y en culturas 
diferentes.
Palabras Clave: Cáncer, malestar emocio-
nal, ansiedad, ira, desesperanza, depresión.
INTRODUCTION
The diagnosis of cancer and the 
aggressive treatments currently available 
to cure the disease are traumatic events 
that have a major impact upon patients 
and their family members. The occurrence 
of significantly elevated levels of anxiety as 
compared to a normal population has been 
reported to be as high as 85% for newly 
diagnosed cancer patients. In addition, the 
incidence of depression in cancer patients 
varies from 20% to 25% in United States(1), 
and 72% to 89% in Sweden(2), with the 
prevalence increasing to 77% for those with 
advanced illness(3). Despite this increased 
attention to control these troublesome 
symptoms in patients with cancer, there 
have been no concerted efforts to address 
the assessment of emotional distress based 
on psychometric measures particularly 
developed for cancer patients. 
High emotional distress cancer patients 
experience coping difficulties evidenced 
by a negative and pessimistic attitude 
toward the treatments, and a dismal view 
regarding recovery. More information 
needs to be given to the primary oncologist 
and his/her staff about the recognition 
of significantly high levels of emotional 
distress; how to query the patient to elicit 
adequate information about their feelings, 
and how to identify appropriate resources 
to which the oncological patients could 
be referred for psychological counseling 
and support. In this sense, the recognition 
of perceived emotional distress in cancer 
patients needs to be a top priority within 
psychosocial oncology programs across 
the world(4-7). 
Approximately 50% of all the 
individuals diagnosed with cancer in 
the United States experience significant 
levels of emotional distress, and many of 
these symptoms are unrecognized and 
untreated(8). The diagnosis of cancer and 
the strain caused by the overwhelming 
side effects of its treatments are a perfect 
example of a potential stressors events 
capable of evoking emotional distress(9). 
There is accumulating evidence in the 
literature indicating that cancer patients 
experience significant levels of emotional 
distress at initial diagnosis, at recurrence 
or progression of the disease, and at 
terminal stage(1,10).
CLINICAL SCREENING OF PERCEIVED 
EMOTIONAL DISTRESS
The standardized assessment of perceived 
emotional distress is at least as problematic as 
its own definition. A survey of cancer centers 
in United States reports relying only on 
interviews for the assessments of emotional 
distress for cancer patients, as opposed to 
the utilization of screening instruments(8). 
Unfortunately, there has been relatively 
little systematic and methodological effort 
to evaluate or improve existing measures. 
Cancer programs could clearly benefit 
from a brief, easy to administer, yet 
comprehensive form of evaluation that 
identifies emotionally distressed cancer 
patients, who are experiencing not only 
anxiety and depression, but also anger and 
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hopelessness. The need for a standardized 
measure of perceived emotional distress 
designed to eliminate the potentially 
confounding effects of somatic symptoms 
frequently associated with therapeutic 
treatments in cancer patients has become 
increasingly important. 
Perceived emotional distress is an 
important construct in the field of 
psychooncology, and remains a legitimate 
topic of study(11). Although this concept 
is not comparable to clinical depression 
or major psychiatric illnesses, individuals 
with such diffuse types of complaints 
are in serious need of psychological and 
behavioral interventions in the medical 
field(12,13). We define this state of perceived 
emotional distress as marked by “subjective 
feelings that vary in intensity from sadness, 
uncertainty, confusion and worry to more 
significant symptoms such as anxiety, the 
expression of anger, social isolation and 
hopelessness”. Our conceptual framework 
of the perceived emotional distress 
construct in patients with cancer includes 
the expression of anger, hopelessness, 
and a significant degree of underlying 
multidimensionality, and should be clearly 
distinguished from clinical depression(14).
The clinical screening of perceived 
emotional distress as part of an initial 
psychosocial assessment, may offer an 
opportunity to identify high-risk patients 
before they receive their diagnosis of 
cancer(15). Subsequent assessments of 
perceived emotional distress taken after a 
diagnosis of cancer, following surgery, or 
upon beginning chemotherapy or radiation 
treatments could provide invaluable 
evidence of the need for psychological 
intervention to treat or manage these 
debilitating symptoms(16). Despite the 
negative impact of perceived emotional 
distress on cancer patients and its effects 
on quality of life, the screening for such 
emotional states has not been a consistent 
part of routine procedures in cancer 
programs.
MEASURING PERCEIVED EMOTIONAL 
DISTRESS IN CANCER PATIENTS
It is critically important to recognize that 
conceptual clarity is essential to empirical 
progress. Therefore, in order to develop 
a valid and reliable screening measure, 
we must distinguish perceived emotional 
distress, conceptually and empirically, from 
those factors which are only indirectly 
related to the construct. The distinction 
between somatic distress and emotional 
distress is of critical concern. Somatic 
distress is regarded in the literature as a 
preoccupation with physical symptoms(17). 
However, somatic distress, such as lack of 
appetite, difficulty with sleep, and a lack 
of energy, are not exclusively related to the 
emotional distress construct. Furthermore, 
in the case of cancer patients, somatic 
symptoms are more likely to be due to the 
side effects of cancer treatments than to the 
emotional state of the patient. Consequently, 
in the development of screening measures, 
we should be careful not to include somatic 
symptom items to ensure a valid and reliable 
measurement of perceived emotional 
distress in patients with cancer(18).
The Perceived Emotional Distress 
Inventory (PEDI) is a 15-item, brief self-report 
screening inventory designed to measure 
the presence and severity of emotional 
distress as a multi-factor, general mood 
disorder defined as subjective feelings that 
vary in intensity from sadness, uncertainty, 
confusion and worry to more significant 
symptoms such as anxiety, the expression 
of anger, social isolation and hopelessness 
in cancer patients (see Appendix). 
The PEDI carefully discriminates the 
confounding effects of somatic symptoms 
more commonly associated with cancer 
treatment. The inventory evaluates three 
distinct dimensions of perceived emotional 
distress, which include anxiety/depression, 
hopelessness, and anger expression(19). 
Items describing somatic symptoms 
commonly associated with the treatment 
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of cancer patients were carefully not taken 
into consideration. This is consistent with 
previous studies that report confounding 
issues with those items that assess somatic 
symptoms of emotional distress because 
they overlap with somatic symptoms caused 
by cancer-related treatments(20). In addition, 
the instrument provides clinical decision-
making support at intake and during 
the course of treatment. In responding 
to each PEDI item, patients reported to 
“what extent they had experienced each 
emotional distress-related symptom during 
the past month, including today” by rating 
themselves on a 3-point scale: (0) not at all; 
(1) sometimes; (2) often; (3) very much so. 
The major purpose of this article is to 
report the latest data of the PEDI with a larger 
sample of male and female cancer patients 
and provide further evidence of construct 
validity. The driving force of our research 
has been to counteract the neglected 
responsibility to identify patients with cancer, 
who are at high risk of experiencing elevated 
levels of psychological distress during all 
phases of diagnosis and treatments. Given the 
prevalence of perceived emotional distress in 
the field of oncology, clinical screening of 
this sort provides the opportunity to identify 
vulnerable patients as they attend their 
appointments.
METHOD
Factor analysis is the most important 
method of construct validity and, in this 
case, is central to the measurement of the 
perceived emotional distress construct. 
Exploratory factor analyses rather than 
confirmatory factor analysis were carried 
out, because such analyses were judged to 
be more conservative(21).
Participants
The PEDI was administered to 481 
cancer patients, 312 females (65%) 
and 169 males (35%), who received 
either radiation and/or chemotherapy 
treatment in the outpatient services at St 
Joseph’s Cancer Institute and hospitals 
in Tampa, Florida. A sample size of at 
least 150 participants was determined to 
be necessary to satisfy the subjects-to-
variable (STV) ratio based on the number 
of variables(21,22). They ranged in age from 
22 to 79 years old (median age= 46). 
Minimal inclusion criteria for subjects 
were: (1) 18 years of age or greater; 
(2) no history of psychiatric illness or 
substance abuse; (3) completion of the 
informed consent form. Psychiatric illness 
or substance abuse were considered to 
be potentially confounding factors for 
the evaluation of perceived emotional 
distress. Consequently, 19 patients (4%) 
were ruled out because they had a 
previous history of psychiatric illness or 
were undergoing psychological treatment. 
96 patients (20%) from the total sample 
were Hispanic. The sample consisted of 
patients diagnosed with lung cancer 76 
(16%), breast cancer 178 (37%), prostate 
cancer 156 (32%), colorectal cancer 41 
(9%), and ovarian cancer 30 (6%). 
Instruments
The Perceived Emotional Distress 
Inventory (PEDI) is a 15-item, brief self-
report screening inventory designed to 
measure the presence and severity of 
emotional distress.The PEDI was elaborated 
to provide a simple yet reliable instrument 
for use with cancer patients, and identify 
individuals at high-risk of emotional 
distress when they are first diagnosed with 
cancer or upon receiving treatment(23). 
Procedure
Patients receiving treatment at St Joseph’s 
Cancer Institute and Hospitals were informed 
about the study by the research coordinator. 
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Those who met inclusion criteria to 
participate in the study were provided a 
written informed consent statement. The 
consent form clearly emphasized that 
participation in the study was voluntary, 
and that all information would be strictly 
confidential. The questionnaire packet, 
consisting of demographic data queries and 
the PEDI, were administered during the 
course of their intake for radiation treatment 
sessions at St Joseph’s Center for Radiation 
Therapy and/or chemotherapy treatment 
sessions. Each patient, having been given 
standardized oral and written instructions 
in English completed the demographic 
data information section and assessment 
inventory. The study was approved by the St 
Joseph’s Hospital Institutional Review Board.
RESULTS
The means, standard deviations, alpha 
coefficients, and item-reminder correlations 
for the PEDI, the Anxiety, Depression, 
Hopelessness, Expression of Anger subscales, 
and the 15 individual items are reported in 
Table 1. The alpha for the total PEDI scale is 
significantly high at .92 as well as the alphas 
for the brief four item subscales, ranging from 
.79 to .88. The item remainder correlations 
Table 1. Means, standard deviations, and alpha coefficients/item remainder 
correlations of the Perceived Emotional Distress Inventory (PEDI) for a combined 
sample of male and female cancer patients.
MEASURE/ITEM                  Mean Std Dev Alpha/I.R.
EDI (Emotional Distress Inventory) 28.62 9.24 92
EDI: Anxiety 8.12 2.42 0.86
 I feel strained (2) 2.41 0.83 0.69
 I feel nervous (5) 2.61 0.87 0.68
 I feel confused and restless (6) 1.97 0.86 0.74
 I feel overwhelmed by “simple difficulties” (7) 1.98 0.91 0.66
EDI: Depression 7.94 3.02 0.88
 I worry that my condition will get worse (8) 2.48 0.91 0.67
 I feel sad (14) 2.14 0.93 0.78
 I am not enjoying the things I usually do for fun (9) 2.08 1.01 0.59
EDI: Hopelessness 6.24 2.01 0.79
 I feel distant from my friends (3) 1.87 0.87 0.59
 I am losing hope in the fight against my illness (10) 1.48 0.72 0.58
 I feel like a failure (15) 1.62 0.71 0.56
 I am losing faith in my medical treatment (12) 1.47 0.51 0.43
EDI: ANGER 7.14 2.56 0.81
 I get easily irritated (1) 2.09 0.85 0.56
 I am angrier than I am willing to admit (4) 1.93 0.84 0.69
 I feel angry (13) 1.86 0.71 0.68
 I “boil inside”. but I try not to show it (11) 1.62 0.71 0.49
The number in parentheses refer to the number of the items in the instrument.
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of .43 or greater provides further evidence 
of strong internal consistency for each of the 
brief 4 item subscales. 
The responses to the 15 items 
comprising the Perceived Emotional 
Distress Inventory (PEDI) were subjected to 
principle components factor analyses with 
promax rotations, for a combined sample 
of male and female cancer patients. Our 
sample was appropriate for the purpose of 
performing this type of factor analysis as 
indicated by Kaiser-Meyer-Olkin (KMO) 
measure of sampling adequacy >0.634, and 
the Bartlett’s test of sphericity (p<0.001) was 
Table 2. Factorial analysis of the Perceived Emotional Distress Inventory (PEDI) 
items for a sample of male and female cancer patients
Emotional              Factor 1 Factor 2 Factor 3
Distress Inventory            Dep/Anx Hopeless Anger
EDI: Anxiety                    
 I feel strained (2)      0.76
 I feel nervous (5)       0.74
 I feel confused and restless (6)  0.61
 I feel overwhelmed by “simple difficulties” (7) 0.73
EDI: Depression                  
 I worry that my condition will get worse (8) 0.48
 I feel sad (14)      0.79
 I am not enjoying the things I usually do for fun 
(9)      
0.68
EDI: Demoralization                 
 I feel distant from my friends (3) 0.56
 I am losing hope in the fight against my illness 
(10)
0.72
 I feel like a failure (15) 0.74
 I am losing faith in my medical treatment (12) 0.66
EDI: Anger                    
 I get easily irritated (1)  0.45
 I am angrier than I am willing to admit (4) 0.79
 I feel angry (13) 0.47
 I “boil inside”, but I try not to show it (11) 0.62
Eigenvalue 7.54 1.57 2.34
       Inter-factor Correlations Factor 1 - Factor 2 = 0.64 
              Factor 1 - Factor 3 = 0.58
              Factor 2 - Factor 3 = 0.54
The number in parentheses refer to the number of the items in the instrument.
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significant, therefore suitable. Well defined 
anxiety/depression as a main factor, and 
hopelessness and anger expression as two 
small factors, with Eigen values greater than 
1.0 were found. The scree test and breaks 
criterion suggested that three factors should 
be extracted. The three factor promax 
solution for the combined sample provided 
a clear simple structure. The strong inter-
factor correlations among these factors, .54 
or greater, provide the statistical rational for 
using the promax rotation solutions. The 
salient factor loadings, equal to or greater 
than .45, are reported in Table 2 for the 15 
items. Factor 1 consisted of seven items with 
dominant salient item loadings ranging from 
0.48 to 0.79 reflect symptoms of anxiety and 
depression, whereas Factor 2 was comprised 
of four items with strong dominant loadings 
ranging from .56 to .74. The content of the 
items comprising this factor reflected losing 
hope, losing faith, feeling like a failure, and 
social isolation. Factor 3 was composed of 
four items with content relating to anger 
expression. This factor also presented with 
strong and dominant loadings ranging 
from .45 to .79 (see Table 2). These results 
are consistent with previous findings with 
different sample of cancer patients reported 
on the development of the PEDI(19).
Pearson correlation coefficients analysis 
was used to evaluate the relationship 
among the PEDI scale, its Anxiety, 
Depression, Hopelessness, and Anger 
scales. The correlations for the cancer 
patients who completed the measure are 
reported in Table 3. As might be expected, 
each of the scales of the PEDI were very 
strongly correlated (p<.001). The greatest 
correlation was among the Anxiety and 
Depression scales, which is consistent with 
our previous study at Morton Plant Hospital 
Cancer Center in Clearwater, Florida.
DISCUSSION AND SUMMARY
The purpose of this research was to 
present the latest development of the PEDI 
as a brief and psychometrically sound 
screening inventory for the assessment of 
the perceived emotional distress in cancer 
patients by providing further evidence of 
construct validity. This empirical report 
does not present any data related to 
Table 3: Pearson correlation coefficients analysis for a sample of male and female 
cancer patients for the Perceived Emotional Distress Inventory (PEDI), its Anxiety 
(ANX), Depression (DEP), Hopelessness (HOP), and Anger (ANG) subscales.
 PEDI ANX DEP HOP  ANG
 PEDI 0.88 0.81 0.84 0.89
 ANX 0.88 0.71 0.60 0.65
 DEP 0.81 0.71 0.59 0.44
 HOP 0.84 0.60 0.59 0.53
 ANG 0.89 0.65 0.44 0.53
All correlations were significant at the p <.001 level.
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concurrent validity of the PEDI because 
it was previously reported somewhere 
else(19). The underlying reasoning for our 
ongoing research efforts has been the need 
to efficiently identify patients at high-risk of 
experiencing significant levels of emotional 
distress when they receive their diagnosis 
of cancer, undergo surgery, or when they 
begin chemotherapy or radiation treatment. 
The PEDI was designed to provide clinical 
decision-making support at intake and 
during the course of their oncological 
treatments by concisely evaluating four 
major dimensions of perceived emotional 
distress: anxiety, depression, anger and 
hopelessness.
In examining the factor structure of the 
PEDI, a three-factor solution had the best simple 
structure and was most meaningful, providing 
valuable information on the component 
dimensions of perceived emotional distress. A 
factor solution was considered to have good 
simple structure when each item loaded 
unambiguously on one factor(24). Salient items 
were identified as possessing factor loadings 
equal to or greater than 0.45. In this sense, the 
assessment of perceived emotional distress in 
cancer patients offers a coherent theoretical 
framework that includes anxiety, depression 
as well as the expression of anger and 
hopelessness related constructs(25). In previous 
studies of psychological distress, anger has 
been underestimated because of the belief 
that anger is a normal and logical emotional 
reaction to a life threatening illnesses, 
particularly within a cross-cultural context(26).
We found a very strong first factor 
comprised of seven items with loadings 
ranging from 0.48 to 0.79, assessing anxiety 
and depression. Although depression and 
anxiety have been viewed as independent 
and conceptually distinct syndromes, the 
ability to differentiate between depression 
and anxiety on self-report measures 
has proven to be very difficult(27). This is 
particularly true in self-report instruments 
that have not taken into consideration 
items reflecting symptoms of somatic 
anxiety and somatic depression. 
A second factor was comprised of 
four items with strong dominant loadings 
ranging from 0.56 to 0.74. The pessimistic-
oriented nature of the items in this particular 
factor may indicate that hopelessness has 
both, a negative affectivity and a cognitive 
component, or perhaps that these items tap 
social isolation and “a sense of giving up” 
in cancer patients. Since the experience 
of these feelings is commonly reported 
by cancer patients after being informed 
of recurrence, or that the condition has 
become terminal, the emergence of this 
factor as an independent dimension for 
this sample of cancer patients is not at all 
surprising.
Consistent with our previous studies 
on the PEDI, we report a third factor with 
items that relate to anger expression. We 
had initially expected a one-dimensional, 
bipolar factor of anger expression given 
the small number of items, which the 
data clearly supported in this third 
factor. Thus, rather than assessing two 
relatively independent dimensions of 
anger expression as in the preliminary 
study by Moscoso et al.(14), the items 
seemed to suggest a single bipolar factor. 
Our previous factor analyses of the anger 
expression subscale in patients with cancer 
have identified a comparable factor.
The results of the factor analysis for 
the 15-item PEDI clearly indicate that 
this measure provides a valid and reliable 
description of the experience of emotional 
distress in patients with cancer. The factor 
structure of the inventory confirmed the 
assumed structural properties and provided 
empirical support for conceptualizing 
emotional distress as a multi-dimensional 
construct. The strong correlation between 
the PEDI scale and its Anxiety, Depression, 
Anger and Hopelessness subscales were 
expected. The 0.92 coefficient alpha 
for the 15-item instrument indicated 
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significant internal consistency. This is 
impressive when considering that three 
psychometrically discrete and significantly 
correlated dimensions were identified. 
In summary, the results reported in this 
study offer strong empirical evidence of 
good internal consistency and construct 
validity for the measure. The factor analy-
ses are suggesting that the PEDI provides 
significant information about the multidi-
mensional aspects of perceived emotio-
nal distress in cancer patients. However, 
these findings should be taken cautiously. 
The current study presents limitations re-
lated to the oncology population’s spe-
cific characteristics. Further research will 
be needed to provide information about 
the PEDI’s use in populations other than 
cancer patients including attempts to re-
plicate these findings in more heteroge-
neous populations. This study emphasizes 
the need for a brief, self-report instrument 
to assess anger expression, anxiety, de-
pression and hopelessness as components 
of perceived emotional distress in cancer 
patients, while explicitly excluding the 
potentially confounding effects of soma-
tic symptoms commonly associated with 
cancer treatments. In addition, future stu-
dies in this field should distinguish the 
negative affectivity and mood from soma-
tic aspects of anxiety and depression, and 
recognize conceptually and empirically 
the differences between the experience, 
expression, and control of anger(28).
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APPENDIX
PERCEIVED EMOTIONAL DISTRESS INVENTORY
Developed by Manolete S. Moscoso, Ph.D.
Name:  Age:  Sex:   Date: 
Directions: Please read each statement and circle the number (0-1-2-3 ) which best 
describes the way you have been feeling during the past week, including today. Do not 
spend too much time on any one statement but give the answer which describes your 
present feelings.
During the past month, including today....
Not at all  Sometimes Often Very 
Much 
So 
1- I get easily irritated 0 1 2 3
2- I feel strained 0 1 2 3
3- I feel distant from my friends 0 1 2 3
4- I am angrier than I am willing to admit 0 1 2 3
5- I feel nervous 0 1 2 3
6- I feel confused and restless 0 1 2 3
7- I feel overwhelmed by “simple difficulties” 0 1 2 3
8- I worry that my condition will get worse 0 1 2 3
9- I am not enjoying the things I usually do for fun 0 1 2 3
10- I am losing hope in the fight against my illness 0 1 2 3
11- I “boil inside”, but I try not to show it 0 1 2 3
12- I am losing faith in my medical treatment 0 1 2 3
13- I feel angry 0 1 2 3
14- I feel sad 0 1 2 3
15- I feel like a failure 0 1 2 3
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INVENTARIO DE DISTRES EMOCIONAL PERCIBIDO
Elaborado por Manolete S. Moscoso, Ph.D. 
Nombre:  Edad:  Sexo:   Fecha:  
Estado Civil:   Actividad Laboral:  
Instrucciones: Por favor lea cada frase y haga un círculo en el número (0-1-2-3) que 
describa mejor la manera de como se ha sentido últimamente. No tome mucho tiempo 
en cada item, pero de la respuesta que describa mejor tus sentimientos ahora.
Durante el último mes, hasta hoy día
En Ningún 
Momento
A veces Frecuen-
temente
En Todo
Momento
1. Me fastidio fácilmente 0 1 2 3
2. Me siento tenso 0 1 2 3
3. Me siento distante de mis amigos 0 1 2 3
4. Me siento mas enojado de lo que estoy 
dispuesto a admitir
0 1 2 3
5. Me siento nervioso 0 1 2 3
6. Me siento confuso e inquieto 0 1 2 3
7. Me siento agobiado por las “dificultades 
sencillas”
0 1 2 3
8. Me preocupa que mi salud empeore 0 1 2 3
9. No estoy gozando de las cosas que usual-
mente hago para divertirme
0 1 2 3
10. Estoy perdiendo la fe en la lucha contra 
mi enfermedad
0 1 2 3
11. “Estoy que reviento”, pero trato de no 
mostrarlo
0 1 2 3
12. Estoy perdiendo la fe en mi tratamiento 
médico
0 1 2 3
13. Me siento molesto 0 1 2 3
14. Me siento triste 0 1 2 3
15. Siento que soy un fracaso 0 1 2 3
